During this time, treatment is focused on stopping the current OCD episode.
There is growing support for novel dissemination methods for behavioral interventions eg, online-based therapypharmacologic approaches eg, neuroleptic augmentation of antidepressantsand neuromodulation eg, deep-brain stimulation.
We subsequently searched references of retrieved articles for additional reports. Meta-analyses and systematic reviews were prioritized; case series and reports were included only for interventions for which RCTs were not available.
The diagnosis of OCD was revised for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, which addresses OCD separately from anxiety disorders and contains specifiers to delineate the presence of tics and degree of insight.
Treatment advances include increasing evidence to support the efficacy of online-based dissemination of cognitive behavioral therapies, which have demonstrated clinically significant decreases in OCD symptoms when conducted by trained therapists.
Current evidence continues to support the use of selective serotonin reuptake inhibitors as first-line pharmacologic interventions for OCD; however, more recent data support the adjunctive use of neuroleptics, deep-brain stimulation, and neurosurgical ablation for treatment-resistant OCD.
Preliminary data suggest safety of other agents eg, riluzole, ketamine, memantine, N-acetylcysteine, lamotrigine, celecoxib, ondansetron either in combination with selective serotonin reuptake inhibitors or as monotherapy in the treatment of OCD, although their efficacy has not yet been established.
Although cognitive behavioral therapy with or without selective serotonin reuptake inhibitors remains a preferred initial treatment strategy, increasing evidence that supports the safety and efficacy of neuroleptics and neuromodulatory approaches in treatment-resistant cases provides alternatives for patients whose condition does not respond to first-line interventions.Body dysmorphic disorder (BDD) is a disabling illness with a high worldwide prevalence.
Patients demonstrate a debilitating preoccupation with one or more perceived defects, often marked by poor insight or delusional convictions.
Multiple studies have suggested that selective serotonin reuptake.
Many patients who have obsessive‐compulsive disorder (OCD) also meet criteria for additional diagnoses such as mood, anxiety, and personality disorders. The presence of severe depression, and major depressive disorder per se, impedes response to treatment for OCD .
In a previous article we reviewed a range of treatments that are used to help clients suffering from obsessive-compulsive disorder (OCD). In this edition we showcase the case study of Darcy [fictional name], who worked with a psychologist to address the symptoms and history of her OCD.
Obsessive-Compulsive Personality Disorder: Case Presentation and Treatment Plan Within these United States obsessive-compulsive personality disorder (OCPD) affects 1% of the populace of which 3%% of mental health patients are sufferers (rutadeltambor.com, ). Obsessive-compulsive disorder (OCD) is characterized by repetitive, unwanted, intrusive thoughts (obsessions) and irrational, excessive urges to do certain actions (compulsions).
Although people with OCD may know that their thoughts and behavior don't make sense, they are often unable to stop them. Kettl PA, Marks IM. Neurological factors in obsessive compulsive disorder.
Two case reports and a review of the literature.
Br J Psychiatry. Sep; – Marks I, O'Sullivan G. Drugs and psychological treatments for agoraphobia/panic and obsessive-compulsive disorders: a review. Br J Psychiatry.